Immunophenotypic characterization of IgVH3-72 B-cell chronic lymphocytic leukaemia (B-CLL)

Leuk Res. 2006 Sep;30(9):1197-9. doi: 10.1016/j.leukres.2005.11.019. Epub 2006 Jan 18.

Abstract

The frequent expression of the otherwise rare IgVH3-72 gene was demonstrated in highly stable B-cell chronic lymphocytic leukaemias (B-CLLs). Here we describe the immunophenotypic profiles of eleven IgVH3-72 B-CLLs, by investigating expression of ZAP-70 and of a set of surface antigens previously demonstrated to represent the signature of distinct B-CLL prognostic groups. All IgVH3-72 B-CLLs revealed a homogeneous immunophenotypic profile, expressing all the markers associated with good prognosis, but not those representing the signature of bad prognosis B-CLLs, including ZAP-70. Our results corroborate the notion that IgVH3-72 B-CLLs represent a molecularly and immunophenotypically homogeneous disease group with a good prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers, Tumor / immunology*
  • Female
  • Humans
  • Immunoglobulin Heavy Chains / immunology*
  • Immunoglobulin Variable Region / immunology*
  • Immunophenotyping
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Male
  • Middle Aged
  • Prognosis
  • ZAP-70 Protein-Tyrosine Kinase / immunology*

Substances

  • Biomarkers, Tumor
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Variable Region
  • ZAP-70 Protein-Tyrosine Kinase